Jiangsu
688670.SSJiangsu gdk Biotechnology Co., Ltd. Price (688670.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
122,397,017
(0.6519)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Jiangsu gdk Biotechnology Co., Ltd.Currency: CNY
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0.00
+0% |
0.00
+0% |
67,151,263.00
+0% |
589,098,682.00
+777% |
392,272,487.00
-33% |
318,486,074.00
-19% |
134,591,377.00
-58% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 0.00 | 21,068,500.00 | 10,494,712.00 | 73,670,399.00 | 57,178,765.00 | 50,588,057.00 | 29,864,436.00 | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
0.00
+0% |
-21,068,500.00
+0% |
56,656,551.00
-369% |
515,428,283.00
+810% |
335,093,722.00
-35% |
267,898,017.00
-20% |
104,726,941.00
-61% |
||||||||||||
| Gross Profit Ratio | (0.00%) | (0.00%) | (0.84%) | (0.87%) | (0.85%) | (0.84%) | (0.78%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 18,315,545.00 | 12,077,255.00 | 23,753,901.00 | 28,533,101.00 | 35,259,882.00 | 32,409,476.00 | 15,471,820.00 | ||||||||||||
| General and Administrative | 7,650,938.00 | 7,306,211.00 | 7,607,035.00 | 24,157,699.00 | 12,566,477.00 | 12,992,569.00 | 13,489,858.00 | ||||||||||||
| Selling, General & Admin... | 7,650,938.00 | 7,306,211.00 | 33,579,774.00 | 233,290,400.00 | 128,839,803.00 | 120,486,924.00 | 81,938,610.00 | ||||||||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 25,972,739.00 | 209,132,701.00 | 116,273,326.00 | 107,494,355.00 | 68,448,751.00 | ||||||||||||
| Depreciation and Amortiz... | 18,624,011.00 | 21,068,500.00 | 23,297,100.00 | 25,807,200.00 | 29,205,409.00 | 31,137,879.00 | 31,250,895.00 | ||||||||||||
| Other Expenses | 25,392.00 | -7,366.46 | 24,444,330.00 | 16,165,109.00 | 27,915,660.00 | 36,822,225.00 | 82,005,471.00 | ||||||||||||
| Total Operating Expenses | 44,236,225.00 | 38,775,081.00 | 81,778,007.00 | 277,988,610.00 | 192,015,346.00 | 189,718,626.00 | 179,415,902.00 | ||||||||||||
| Cost and Exponses | 44,236,225.00 | 38,775,081.00 | 92,272,720.00 | 351,659,010.00 | 249,194,112.00 | 240,306,684.00 | 209,280,338.00 | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-47,329,199.71
+0% |
-41,355,896.64
-13% |
-25,121,456.07
-39% |
211,741,580.00
-943% |
150,792,997.00
-29% |
95,160,610.00
-37% |
-81,670,600.00
-186% |
||||||||||||
| Operating Income Ratio | (0.00%) | (0.00%) | (-0.37%) | (0.36%) | (0.38%) | (0.30%) | (-0.61%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 4,539.43 | 4,460.79 | 6,874.02 | 265,963.00 | 2,748,485.00 | 1,660,984.00 | 1,899,369.00 | ||||||||||||
| Interest Expenses | 3,243,947.00 | 2,656,118.00 | 2,966,939.00 | 9,640,188.00 | 9,854,942.00 | 1,281,456.00 | 1,898,001.00 | ||||||||||||
| Total Other Income/Exp... | 25,392.00 | -7,366.46 | -6,125,123.93 | -812,930.00 | 34,351.00 | -529,596.00 | -4,903,361.00 | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -25,260,454.35 | -19,655,768.00 | -4,982,602.31 | 246,394,554.00 | 121,932,060.00 | 79,449,495.00 | -53,380,716.00 | ||||||||||||
| EBITDA ratio | (0.00%) | (0.00%) | (-0.03%) | (0.45%) | (0.46%) | (0.39%) | (-0.40%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -47,303,807.12 | -41,363,263.10 | -31,246,580.14 | 210,928,650.00 | 84,001,023.00 | 48,409,055.00 | -86,573,961.00 | ||||||||||||
| Income Before Tax Ratio | (0.00%) | (0.00%) | (-0.47%) | (0.36%) | (0.21%) | (0.15%) | (-0.64%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -14,642,220.00 | -13,350,121.91 | -12,208,890.23 | 55,949,220.00 | 1,540,803.00 | 6,864,707.00 | -15,583,691.00 | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -32,661,587.12
+0% |
-28,013,141.19
-14% |
-19,037,689.91
-32% |
154,979,429.00
-914% |
82,460,219.00
-47% |
41,544,347.00
-50% |
-70,990,269.00
-271% |
||||||||||||
| Net Income Ratio | (0.00%) | (0.00%) | (-0.28%) | (0.26%) | (0.21%) | (0.13%) | (-0.53%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -0.46 | -0.40 | -0.15 | 1.26 | 0.67 | 0.34 | -0.58 | ||||||||||||
| Diluted EPS | -0.65 | -0.40 | -0.15 | 1.26 | 0.67 | 0.34 | -0.58 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 70,348,034.00 | 70,032,847.00 | 123,200,123.00 | 123,200,123.00 | 123,200,123.00 | 123,200,123.00 | 122,397,017.00 | ||||||||||||
| Diluted Share Outstanding | 50,248,596.00 | 70,032,853.00 | 123,200,123.00 | 123,200,123.00 | 123,200,123.00 | 123,200,123.00 | 122,397,017.00 | ||||||||||||